2011
A chemical-genetic screen reveals a mechanism of resistance to PI3K inhibitors in cancer.
Muellner MK,
Uras IZ,
Gapp BV,
Kerzendorfer C,
Smida M,
Lechtermann H,
Craig-Mueller N,
Colinge J,
Duernberger G,
Nijman SM.
Nat Chem Biol. 2011 Nov;7(11):787-93.
2011
Oxidation-specific epitopes are danger-associated molecular patterns recognized by pattern recognition receptors of innate immunity.
Miller YI,
Choi SH,
Wiesner P,
Fang L,
Harkewicz R,
Hartvigsen K,
Boullier A,
Gonen A,
Diehl CJ,
Que X,
Montano E,
Shaw PX,
Tsimikas S,
Binder CJ,
Witztum JL.
Circ Res. 2011 Jan 21;108(2):235-48.
2011
2011
A selective inhibitor and probe of the cellular functions of Jumonji C domain-containing histone demethylases.
Luo X,
Liu Y,
Kubicek S,
Myllyharju J,
Tumber A,
Ng S,
Che KH,
Podoll J,
Heightman TD,
Oppermann U,
Schreiber SL,
Wang X.
J Am Chem Soc. 2011 Jun 22;133(24):9451-6.
2011
Genome integrity of myeloproliferative neoplasms in chronic phase and during disease progression.
Klampfl T,
Harutyunyan A,
Berg T,
Gisslinger B,
Schalling M,
Bagienski K,
Olcaydu D,
Passamonti F,
Rumi E,
Pietra D,
Jager R,
Pieri L,
Guglielmelli P,
Iacobucci I,
Martinelli G,
Cazzola M,
Vannucchi AM,
Gisslinger H,
Kralovics R.
Blood. 2011 Jul 7;118(1):167-76.
2011
Molecular pathogenesis of Philadelphia chromosome negative chronic myeloproliferative neoplasms.
Jager R,
Kralovics R.
Curr Cancer Drug Targets. 2011 Jan;11(1):20-30.
2011
Extra-embryonic-specific imprinted expression is restricted to defined lineages in the post-implantation embryo.
Hudson QJ,
Seidl CI,
Kulinski TM,
Huang R,
Warczok KE,
Bittner R,
Bartolomei MS,
Barlow DP.
Dev Biol. 2011 May 15;353(2):420-31.
2011
After the grape rush: sirtuins as epigenetic drug targets in neurodegenerative disorders.
Huber K,
Superti-Furga G.
Bioorg Med Chem. 2011 Jun 15;19(12):3616-24.
2011
An RNA-Seq strategy to detect the complete coding and non-coding transcriptome including full-length imprinted macro ncRNAs.
Huang R,
Jaritz M,
Guenzl P,
Vlatkovic I,
Sommer A,
Tamir IM,
Marks H,
Klampfl T,
Kralovics R,
Stunnenberg HG,
Barlow DP,
Pauler FM.
PLoS One. 2011;6(11):e27288.
2011
Identification of oncostatin M as a STAT5-dependent mediator of bone marrow remodeling in KIT D816V-positive systemic mastocytosis.
Hoermann G,
Cerny-Reiterer S,
Perne A,
Klauser M,
Hoetzenecker K,
Klein K,
Mullauer L,
Groger M,
Nijman SM,
Klepetko W,
Valent P,
Mayerhofer M.
Am J Pathol. 2011 May;178(5):2344-56.
